Stock Analysis of Comera Life Sci HLDG Inc. (CMRA) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code CMRA
Close 0.0292
Change -0.0015 / 4.89 %
Volume 340.00
Vol Change -1742.00 / 83.67 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Good Stability


Fundamental View of Comera Life Sci HLDG Inc.
PE (TTM)

-0.0001

Very Poor
Price / Book

-0.0012

Very Poor
Price / Sales

0.0006

Excellent
Piotroski F Score

3.0

Not Good
Market Cap

897543

Enterprise Value

897543

ROA (TTM)

-379.05

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

-755.90

Very Poor
Revenue

58.02 %

1000.40 K
Net Profit

49.96 %

-9009.24 K
Debt to Equity

0

Excellent
Altman Z Score

Indecisive
Quick Ratio

0

Poor
Cash Ratio

0

Poor


Highs/Lows of Comera Life Sci HLDG Inc.
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.0212 37.74 % 1.54 % 0.03110.02113-May-2414-May-24
Two Week0.03 2.67 % 3.42 % 0.03110.02113-May-2414-May-24
One Month0.041 28.78 % 5.60 % 0.0410.02123-Apr-2414-May-24
Three Month0.035 16.57 % 5.95 % 0.05990.02108-Mar-2414-May-24
Six Months0.0425 31.29 % 17.48 % 0.1280.02106-Dec-2314-May-24
One year0.6 95.13 % 27.52 % 0.720.02101-Aug-2314-May-24
Two year10.26 99.72 % 29.70 % 2.8950.02116-Sep-2214-May-24


Technical View of Comera Life Sci HLDG Inc.
RSI

45.59

Neutral
MACD

-0.0043

Bearish
ADX

20.76

Neutral
Super Trend

0.0383

Mild Bearish
Williams %R

-59.00

Neutral
CCI

-51.16

Neutral


EMA 5

0.0270

Strong Bullish
EMA 15

0.0305

Neutral
EMA 50

0.0409

Strong Bearish
EMA 100

0.082

Strong Bearish
SMA 100

0.0494

Mild Bearish
SMA 200

0.206

Strong Bearish
SMA 5 / 20

0.0247 / 0.0356

Strong Bearish
SMA 15 / 50

0.0315 / 0.0387

Strong Bearish
SMA 50 / 200

0.0387 / 0.206

Mild Bearish




Charts of Comera Life Sci HLDG Inc.


Returns of Comera Life Sci HLDG Inc. with Peers
Period / StockCMRAHTGMNEPTHSTO
1 Week37.74%-13.48%-57.89%5.00%
1 Mth-28.78%-75.56%-57.89%-58.00%
3 Mth-16.57%-82.92%-61.98%-37.31%
6mth-31.29%-88.77%-96.87%-38.24%
1 Year-95.13%-97.00%-99.09%-72.73%
2 Year-99.72%-99.37%-99.96%-94.57%
5 Years--99.93%-100.00%-99.88%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Comera Life Sci HLDG Inc. with Peers
Ratio / StockCMRAHTGMNEPTHSTO
PE-0.0001-0.079-0.0112-52.30
P/B-0.00120.794-0.020563.95
ROA-379.05-175.05-416.28-83.91
ROE0-562.450-111.37
Debt To Equity00.537-1.950
Revenue1000.40 K
58.02 % 		6366.22 K
28.52 % 		52615.34 B
107824570 % 		19000.00
99.50 %
Net Income-9009.24 K
49.96 % 		-21594.48 K
25.95 % 		-170880.45 B
241130345 % 		-12377.00 K
11.41 %


Technicals of Comera Life Sci HLDG Inc. with Peers
Technical / StockCMRAHTGMNEPTHSTO-
ADX20.7635.6722.4131.97
CMF0.307-0.386-0.5770.291
MFI2.418.5179.4849.11
RSI45.5918.0030.8639.29
MACD Abv SignalFalseFalseFalseFalse
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Comera Life Sciences Holdings Inc

Address : 12 Gill Street, Woburn, MA, United States, 01801
Tel : 617 871 2101
URL : https://comeralifesciences.com
Code : CMRA, ISIN : US20037C1080, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 19_May_2022
Employee Count : 12

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)